Skip links

Author: staff

WHO approves first African-manufactured malaria drug

12 November 2023 The Independent The combination therapy for seasonal malaria chemoprevention is made in Kenya Kampala, Uganda | THE INDEPENDENT | A leading Kenya-based pharmaceutical manufacturer, Universal Corporation Ltd (UCL), has become the first African manufacturer to gain WHO prequalification for their sulfadoxine-pyrimethamine + amodiaquine

MED ADITUS NEWS: Appointment of Robert A. Blouin as President & Chief Executive Officer and Launch of Subsidiary, Med Aditus Pharmaceuticals, Inc.

FOR IMMEDIATE RELEASE Media Contact: Chiara Canzi Chief Communications Officer [email protected] (434) 249-5930 www.medaditus.org Med Aditus International Announces Appointment of Robert A. Blouin as President & Chief Executive Officer and Launch of Subsidiary, Med Aditus Pharmaceuticals, Inc.   RESEARCH TRIANGLE PARK, NC, (November 16, 2023)

Africa: Identifying Opportunities for Sustainable Financing for Neglected Tropical Diseases

28 September 2023 By Nontobeko Mlambo Gaborone — During the World Health Organization’s 73rd Africa Regional Committee held in Botswana, AllAfrica’s Nontobeko Mlambo spoke to Thoko Elphick-Pooley, Executive Director of Uniting to Combat Neglected Tropical Diseases (NTDs) to discuss progress made in eliminating NTDs in Africa. Neglected Tropical Diseases affect over a billion people

Fear of new TB infections after drugs shortage hits sixth month

14 October 2023 By Mercy Kahenda Kenya is likely to lose gains made in the fight against Tuberculosis (TB), a leading infectious disease, following an acute shortage of drugs. According to sources, the nationwide shortage has been experienced in the past six months. Evelyn Kibuchi, head of Stop